Neuphoria Therapeutics (NEUP) Q1 2025 Earnings

14FebConfirmed
Q4 2024
Q1 2025
-2.01
-1.5
-0.98
-0.47

Details

Expected EPS
-0.47
Actual EPS
-1.23
Surprise EPS
-0.76
Surprise Percent
+161.7%

Description

Neuphoria Therapeutics (NEUP) has reported earnings of -1.23 per share for Q1 2025.

0 Comments

Share your thoughts